Tyrstrup Mia, Melander Eva, Hedin Katarina, Beckman Anders, Mölstad Sigvard
Department of Clinical Sciences, Family Medicine, Lund University, Malmö, Sweden.
Department of Translational Medicine, Lund University, Malmö, Sweden.
BMC Infect Dis. 2017 Sep 4;17(1):603. doi: 10.1186/s12879-017-2703-3.
The majority of antibiotics consumed in developed countries are prescribed in primary care. However, little is known about resistance levels in the primary care population.
Nasopharyngeal cultures were obtained from children, 0-10 years of age, seeking care at their Primary Health Care Centre with symptoms of respiratory tract infection. Parental questionnaires were used to retrieve information about the child's previous antibiotic consumption.
Cultures from 340 children were gathered. The level of resistant Haemophilus influenzae was low and the prevalence of penicillin non-susceptible pneumococci (PNSP MIC ≥ 0.125 mg/L) was 6% compared to 10% (p = 0.31) in corresponding cultures from children diagnosed at the local clinical microbiology laboratory. Antibiotic treatment within the previous 4 weeks predisposed for resistant bacteria in the nasopharynx, OR: 3.08, CI 95% (1.13-8.42).
Low prevalence of PNSP supports the use of phenoxymethylpenicillin as empirical treatment for childhood upper respiratory tract infections attending primary care in our setting. It is important that studies on resistance are performed in primary care populations to evaluate data from microbiological laboratories. Recent antibiotic treatment increases risk of bacterial resistance in children and continuous work to reduce unnecessary antibiotic prescribing should be prioritised.
在发达国家,大部分抗生素是在初级保健中开具的。然而,对于初级保健人群中的耐药水平了解甚少。
从0至10岁因呼吸道感染症状到初级卫生保健中心就诊的儿童中获取鼻咽培养物。使用家长问卷来获取有关孩子以前抗生素使用情况的信息。
收集了340名儿童的培养物。流感嗜血杆菌的耐药水平较低,青霉素不敏感肺炎球菌(PNSP MIC≥0.125mg/L)的患病率为6%,而在当地临床微生物实验室诊断的儿童相应培养物中这一患病率为10%(p = 0.31)。前4周内使用抗生素治疗使鼻咽部出现耐药菌的倾向增加,比值比:3.08,95%可信区间(1.13 - 8.42)。
PNSP的低患病率支持在我们的环境中使用苯氧甲基青霉素作为初级保健中儿童上呼吸道感染的经验性治疗。在初级保健人群中开展耐药性研究以评估微生物实验室的数据很重要。近期使用抗生素治疗会增加儿童细菌耐药的风险,应优先持续努力减少不必要的抗生素处方。